Halozyme Therapeutics, Inc. HALO
$98.66
-2.00%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (6 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $91.33
- Implied Upside
- -7.4%
- Price Target Range
- $56.00 – $115.00
- Analysts (12 mo)
- 9
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-07 | Leerink PartnersDavid Risinger |
Upgrades | Market perform → Outperform | $83 → $110 |
| 2026-08-07 | TD CowenBrendan Smith |
Maintains | Buy | $96 → $105 |
| 2026-08-07 | CitizensJason N. Butler |
Maintains | Market outperform | $92 → $93 |
| 2026-08-07 | Wells FargoMohit Bansal |
Maintains | Equal-weight | $75 → $95 |
| 2026-08-07 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $95 → $115 |
| 2026-07-21 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $95 |
| 2026-05-12 | Morgan StanleyVikram Purohit |
Maintains | Overweight | $96 → $93 |
| 2026-04-29 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $90 → $95 |
| 2026-02-19 | BenchmarkRobert Wasserman |
Maintains | Buy | $75 → $90 |
| 2026-02-19 | Wells FargoMohit Bansal |
Maintains | Equal-weight | $65 → $75 |
| 2026-01-08 | TD CowenBrendan Smith |
Maintains | Buy | $79 → $90 |
| 2025-12-19 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $90 |
| 2025-11-28 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $90 |
| 2025-11-18 | Goldman SachsGraig Suvannavejh |
Maintains | Neutral | $54 → $56 |
| 2025-11-04 | CitizensJason Butler |
Maintains | Market outperform | $91 → $92 |
| 2025-10-27 | JP MorganJessica Fye |
Maintains | Neutral | $63 → $65 |
| 2025-10-20 | Morgan StanleyVikram Purohit |
Maintains | Overweight | $80 → $79 |
| 2025-10-15 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $90 |
| 2025-10-14 | Leerink PartnersDavid Risinger |
Upgrades | Underperform → Market perform | $70 |
| 2025-10-02 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $85 → $90 |
| 2025-09-24 | BenchmarkRobert Wasserman |
Maintains | Buy | $75 → $90 |
| 2025-09-22 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $75 → $85 |
| 2025-08-18 | Morgan StanleyVikram Purohit |
Maintains | Overweight | $75 → $80 |
| 2025-08-07 | JP MorganJessica Fye |
Maintains | Neutral | $60 → $63 |
| 2025-08-06 | JMP SecuritiesJason N. Butler |
Maintains | Market outperform | $91 → $78 |
| 2025-08-06 | HC Wainwright & Co.Mitchell Kapoor |
Maintains | Buy | $72 → $75 |
| 2025-08-06 | Morgan StanleyVikram Purohit |
Upgrades | Equal-weight → Overweight | $62 → $75 |
| 2025-07-16 | JP MorganJessica Fye |
Maintains | Neutral | $58 → $60 |
| 2025-05-29 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Buy | $72 |
| 2025-05-14 | Morgan StanleyVikram Purohit |
Downgrades | Overweight → Equal-weight | $73 → $62 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $98.66
- Market Cap
- $11.20 billion
- 52-Week Range
- $55.64 – $104.78
- Average Volume
- 2.18 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.